Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) Stock Analysis
DELISTED 2026
What happened to Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) stock?
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) no longer trades on public markets. It was delisted in March 2026. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- March 2026
- Last recorded price (historical):
- $400.00 (last quote on record before the March 2026 delisting; historical, not a current quote)
P/E 6.74 means the share price is 6.74 times one year of earnings per share.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
This page is the archived listing record for Bristol-Myers Squibb Company PFD CONV 2 (BMYMP), kept for historical reference only.
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) Healthcare & Pipeline Overview
Bristol-Myers Squibb Company PFD CONV 2 ADR Information Unsponsored
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 1
- ADR Ratio: 1:1
BMYMP OTC Market Information
BMYMP trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy BMYMP shares?
No. BMYMP stopped trading on public markets in March 2026, so the shares are not available through a broker. Anything you see quoted for BMYMP elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BMYMP stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Bristol-Myers Squibb Company PFD CONV 2. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.